Is Acutus Medical, Inc. technically bullish or bearish?
2025-09-20 19:22:03As of 21 July 2025, the technical trend for Acutus Medical, Inc. has changed from bearish to mildly bearish. The weekly MACD indicates a mildly bullish stance, while the monthly MACD is also mildly bullish. However, the monthly RSI is bearish, and the daily moving averages are mildly bearish. The KST shows a mildly bullish trend on the weekly but is bearish on the monthly. Both the Bollinger Bands and Dow Theory reflect a sideways trend with no clear direction. In terms of performance, the stock has significantly underperformed against the S&P 500 across multiple periods, with a year-to-date return of -99.27% compared to the S&P 500's 12.22%. Overall, the current technical stance is mildly bearish, driven primarily by the mixed signals from MACD and moving averages....
Read MoreIs Acutus Medical, Inc. overvalued or undervalued?
2025-09-20 17:57:19As of 12 November 2020, Acutus Medical, Inc. moved from a grade of does not qualify to risky, indicating a significant deterioration in its valuation outlook. The company appears to be overvalued given its negative financial metrics, including a P/E ratio of 0, a Price to Book Value of -0.01, and an EV to EBITDA of -3.84. Comparatively, peers such as LENSAR, Inc. and NeuroOne Medical Technologies Corp. exhibit similarly risky valuations with P/E ratios of -10.55 and -6.96, respectively. The stock has underperformed significantly against the S&P 500, with a year-to-date return of -99.27% compared to the S&P 500's positive return of 12.22%. This stark contrast reinforces the notion that Acutus Medical, Inc. is overvalued in its current state....
Read More





